200 related articles for article (PubMed ID: 22319003)
41. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells.
Hurst SM; McLoughlin RM; Monslow J; Owens S; Morgan L; Fuller GM; Topley N; Jones SA
J Immunol; 2002 Nov; 169(9):5244-51. PubMed ID: 12391243
[TBL] [Abstract][Full Text] [Related]
42. IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression.
Suzuki M; Hashizume M; Yoshida H; Shiina M; Mihara M
Cytokine; 2010 Aug; 51(2):178-83. PubMed ID: 20403707
[TBL] [Abstract][Full Text] [Related]
43. Decreased IL-1β-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells.
Akkouh IA; Ueland T; Hansson L; Inderhaug E; Hughes T; Steen NE; Aukrust P; Andreassen OA; Szabo A; Djurovic S
Brain Behav Immun; 2020 Jul; 87():634-644. PubMed ID: 32109548
[TBL] [Abstract][Full Text] [Related]
44. Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule.
Suzuki M; Hashizume M; Yoshida H; Mihara M
Rheumatol Int; 2010 Jan; 30(3):309-15. PubMed ID: 19466425
[TBL] [Abstract][Full Text] [Related]
45. Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-κB and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis.
Kim SK; Park KY; Yoon WC; Park SH; Park KK; Yoo DH; Choe JY
Joint Bone Spine; 2011 Oct; 78(5):471-7. PubMed ID: 21354845
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter.
Porée B; Kypriotou M; Chadjichristos C; Beauchef G; Renard E; Legendre F; Melin M; Gueret S; Hartmann DJ; Malléin-Gerin F; Pujol JP; Boumediene K; Galéra P
J Biol Chem; 2008 Feb; 283(8):4850-65. PubMed ID: 18065760
[TBL] [Abstract][Full Text] [Related]
47. CCL20 and β-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions.
Ghannam S; Dejou C; Pedretti N; Giot JP; Dorgham K; Boukhaddaoui H; Deleuze V; Bernard FX; Jorgensen C; Yssel H; Pène J
J Immunol; 2011 Feb; 186(3):1411-20. PubMed ID: 21178014
[TBL] [Abstract][Full Text] [Related]
48. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
Li Q; Laumonnier Y; Syrovets T; Simmet T
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
[TBL] [Abstract][Full Text] [Related]
49. Toll-like receptor 5- and lymphotoxin beta receptor-dependent epithelial Ccl20 expression involves the same NF-kappaB binding site but distinct NF-kappaB pathways and dynamics.
Sirard JC; Didierlaurent A; Cayet D; Sierro F; Rumbo M
Biochim Biophys Acta; 2009 May; 1789(5):386-94. PubMed ID: 19303953
[TBL] [Abstract][Full Text] [Related]
50. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts.
Vermes C; Jacobs JJ; Zhang J; Firneisz G; Roebuck KA; Glant TT
J Biol Chem; 2002 May; 277(19):16879-87. PubMed ID: 11884403
[TBL] [Abstract][Full Text] [Related]
51. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
[TBL] [Abstract][Full Text] [Related]
52. Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex.
Coletta I; Soldo L; Polentarutti N; Mancini F; Guglielmotti A; Pinza M; Mantovani A; Milanese C
Exp Nephrol; 2000; 8(1):37-43. PubMed ID: 10644881
[TBL] [Abstract][Full Text] [Related]
53. Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes.
Kanda N; Hau CS; Tada Y; Tatsuta A; Sato S; Watanabe S
Endocrinology; 2011 Aug; 152(8):3155-64. PubMed ID: 21673103
[TBL] [Abstract][Full Text] [Related]
54. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.
Homey B; Dieu-Nosjean MC; Wiesenborn A; Massacrier C; Pin JJ; Oldham E; Catron D; Buchanan ME; Müller A; deWaal Malefyt R; Deng G; Orozco R; Ruzicka T; Lehmann P; Lebecque S; Caux C; Zlotnik A
J Immunol; 2000 Jun; 164(12):6621-32. PubMed ID: 10843722
[TBL] [Abstract][Full Text] [Related]
55. Context-dependent IL-6 potentiation of interferon- gamma-induced IL-12 secretion and CD40 expression in murine microglia.
Lin HW; Levison SW
J Neurochem; 2009 Nov; 111(3):808-18. PubMed ID: 19712053
[TBL] [Abstract][Full Text] [Related]
56. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
57. Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells.
Jougasaki M; Ichiki T; Takenoshita Y; Setoguchi M
Br J Pharmacol; 2010 Mar; 159(6):1294-303. PubMed ID: 20136831
[TBL] [Abstract][Full Text] [Related]
58. Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.
Getschman AE; Imai Y; Larsen O; Peterson FC; Wu X; Rosenkilde MM; Hwang ST; Volkman BF
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12460-12465. PubMed ID: 29109267
[TBL] [Abstract][Full Text] [Related]
59. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
Zeng W; Chang H; Ma M; Li Y
Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
[TBL] [Abstract][Full Text] [Related]
60. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
